20/20 Biolabs Inc share price logo

20/20 Biolabs Inc Share Price

NASDAQ: AIDX

Small Cap

$3.17

-0.22

(-6.49%)

Live

as on

20/20 Biolabs Inc Stock Performance

as on March 4, 2026 at 6:06 am IST

  • Day's Low

    Day's High

    $3.08
    $3.84
    downward going graph

    2.84%

    Downside

    21.14%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

20/20 Biolabs Inc share price movements today

Previous Close
$3.39
Open
$3.15
Volume
718.3K
Day's Low - High
$3.08 - $3.84

20/20 Biolabs Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

20/20 Biolabs Inc Stock Fundamentals & Key Indicators

Check 20/20 Biolabs Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.5M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

20/20 Biolabs Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 20/20 Biolabs Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$39.5MNANA-159.33%
BUY$114.0B96.34%39.6114.44%
BUY$148.3B59.35%46.0712.92%
BUY$125.4B-16.83%27.2813.00%
BUY$202.5B-4.25%31.2814.72%

20/20 Biolabs Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2024
Dec 2024
Sep 2025
Total Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Income
-1
-1
-1
-1
0
EBITDA
-1
-1
-1
-1
0
Interest Expense
0
0
-
-
0
Depreciation
-
-
-
0
-
Income Before Tax
-1
-1
-1
-1
0
Income Tax Expense
-
-
-
-
-
Net Income
-1
-1
-1
-1
0
Net Profit Margin
-475.66%
-511.03%
-518.97%
-232.99%
-197.51%

20/20 Biolabs Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
0
0
2
9
11
1
1
Gross Profit
0
0
0
0
0
4
5
0
0
Operating Income
-2
-1
-1
-2
-2
1
1
-6
-5
EBITDA
-2
-1
-1
-2
-1
2
1
-6
-5
Interest Expense
0
-
-
-
-
0
0
0
0
Depreciation
-
-
-
-
-
-
-
0
0
Income Before Tax
-2
-1
-1
-2
-2
2
2
-6
-5
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-2
-1
-1
-2
-2
2
2
-6
-5
Net Profit Margin
-521.79%
-403.63%
-528.11%
-841.25%
-86.75%
21.53%
19.77%
-448.73%
-316.81%

20/20 Biolabs Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Dec 2024
Net Income
-1
-1
Operating Cash Flow
-1
0
Investing Cash Flow
0
-
Financing Cash Flow
0
0
Change in Cash
-1
1

20/20 Biolabs Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-1
-1
-2
-2
2
2
-6
-5
Operating Cash Flow
-1
-1
-2
-2
-1
5
-4
-2
Investing Cash Flow
0
0
-1
1
0
0
0
-
Financing Cash Flow
1
3
1
3
1
0
0
0
Change in Cash
0
2
-2
2
0
5
-4
-2

Insights on 20/20 Biolabs Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AIDX stock has moved down by -57.5%

About 20/20 Biolabs Inc

20/20 Biolabs Inc, formerly 20/20 GeneSystems, Inc., is a digital diagnostics company, which is engaged in developing and commercializing clinical laboratory tests and associated software that is powered by machine learning and real-word data to improve diagnostic accuracy and clinical usefulness. The Company offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.
Organisation20/20 Biolabs Inc
Headquarters15810 Gaither Road, Gaithersburg, MD, United States, 20877
CEOMr. Jonathan Cohen
E-voting on sharesClick here to vote

Key Management of 20/20 Biolabs Inc

Name

Title

Mr. Alan B. Bergman

Chief Financial Officer

Dr. Michael S. Lebowitz Ph.D.

Chief Scientific Officer

Mr. David Lees

Director of Sales

Mr. Ronald R. Baker

Chief Business Officer

Marc Gordon

Controller

Mr. Jonathan Cohen

Founder, CEO, President & Director

Dr. Jiming Zhou Ph.D.

Chief Operating Officer

FAQs

What is 20/20 Biolabs Inc share price today?

20/20 Biolabs Inc share price today is $3.17 as on . 20/20 Biolabs Inc share today touched a day high of $3.84 and a low of $3.08.

What is the 52 week high and 52 week low for 20/20 Biolabs Inc share?

20/20 Biolabs Inc share touched a 52 week high of $ on and a 52 week low of $ on . 20/20 Biolabs Inc stock price today i.e. is trending at $3.17,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is 20/20 Biolabs Inc's market capitalisation today?

20/20 Biolabs Inc market capitalisation is $0.00T as on .

How to invest in 20/20 Biolabs Inc Stock (AIDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for 20/20 Biolabs Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 20/20 Biolabs Inc Shares that will get you 0.4732 shares as per 20/20 Biolabs Inc share price of $3.17 per share as on March 4, 2026 at 12:36 am IST.

What is the minimum amount required to buy 20/20 Biolabs Inc Stock (AIDX) from India?

Indian investors can start investing in 20/20 Biolabs Inc (AIDX) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in 20/20 Biolabs Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on 20/20 Biolabs Inc share’s latest price of $3.17 as on March 4, 2026 at 12:36 am IST, you will get 3.1546 shares of 20/20 Biolabs Inc. Learn more about fractional shares .